Cargando…

Early relapse of inflammatory breast carcinoma treated with lapatinib and capecitabine: Ten years of complete response

Detalles Bibliográficos
Autores principales: Martin Huertas, Roberto, Fernández Abad, María, Corral de la Fuente, Elena, Serrano Domingo, Juan José, Martínez Jáñez, Noelia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7216947/
https://www.ncbi.nlm.nih.gov/pubmed/31565830
http://dx.doi.org/10.1111/tbj.13606
_version_ 1783532515725672448
author Martin Huertas, Roberto
Fernández Abad, María
Corral de la Fuente, Elena
Serrano Domingo, Juan José
Martínez Jáñez, Noelia
author_facet Martin Huertas, Roberto
Fernández Abad, María
Corral de la Fuente, Elena
Serrano Domingo, Juan José
Martínez Jáñez, Noelia
author_sort Martin Huertas, Roberto
collection PubMed
description
format Online
Article
Text
id pubmed-7216947
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-72169472020-05-13 Early relapse of inflammatory breast carcinoma treated with lapatinib and capecitabine: Ten years of complete response Martin Huertas, Roberto Fernández Abad, María Corral de la Fuente, Elena Serrano Domingo, Juan José Martínez Jáñez, Noelia Breast J Commentaries John Wiley and Sons Inc. 2019-09-29 2020-04 /pmc/articles/PMC7216947/ /pubmed/31565830 http://dx.doi.org/10.1111/tbj.13606 Text en © 2019 The Authors. The Breast Journal published by Wiley Periodicals, Inc This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Commentaries
Martin Huertas, Roberto
Fernández Abad, María
Corral de la Fuente, Elena
Serrano Domingo, Juan José
Martínez Jáñez, Noelia
Early relapse of inflammatory breast carcinoma treated with lapatinib and capecitabine: Ten years of complete response
title Early relapse of inflammatory breast carcinoma treated with lapatinib and capecitabine: Ten years of complete response
title_full Early relapse of inflammatory breast carcinoma treated with lapatinib and capecitabine: Ten years of complete response
title_fullStr Early relapse of inflammatory breast carcinoma treated with lapatinib and capecitabine: Ten years of complete response
title_full_unstemmed Early relapse of inflammatory breast carcinoma treated with lapatinib and capecitabine: Ten years of complete response
title_short Early relapse of inflammatory breast carcinoma treated with lapatinib and capecitabine: Ten years of complete response
title_sort early relapse of inflammatory breast carcinoma treated with lapatinib and capecitabine: ten years of complete response
topic Commentaries
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7216947/
https://www.ncbi.nlm.nih.gov/pubmed/31565830
http://dx.doi.org/10.1111/tbj.13606
work_keys_str_mv AT martinhuertasroberto earlyrelapseofinflammatorybreastcarcinomatreatedwithlapatinibandcapecitabinetenyearsofcompleteresponse
AT fernandezabadmaria earlyrelapseofinflammatorybreastcarcinomatreatedwithlapatinibandcapecitabinetenyearsofcompleteresponse
AT corraldelafuenteelena earlyrelapseofinflammatorybreastcarcinomatreatedwithlapatinibandcapecitabinetenyearsofcompleteresponse
AT serranodomingojuanjose earlyrelapseofinflammatorybreastcarcinomatreatedwithlapatinibandcapecitabinetenyearsofcompleteresponse
AT martinezjaneznoelia earlyrelapseofinflammatorybreastcarcinomatreatedwithlapatinibandcapecitabinetenyearsofcompleteresponse